<DOC>
	<DOC>NCT02849769</DOC>
	<brief_summary>Following product approval, further confirmation of the MR Conditional Tachyarrhythmia Therapy Systems sensing and detection performance post MRI exposure will be obtained by actively monitoring de-identified device data obtained through the Medtronic CareLink® Network.</brief_summary>
	<brief_title>Magnetic Resonance (MR) Conditional Tachyarrhythmia Therapy Products Post-approval Study</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<criteria>MR conditional tachyarrhythmia therapy system enrolled in the Medtronic CareLink® Network (CL) will be used to prospectively assess spontaneous Ventricular Fibrillation (VF) episode detection following MRI exposure.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>